Fundraising FoxVibrant Therapeutics
2 known investors
Find your way into Vibrant Therapeutics
Sign up to find every way you can get introduced to Vibrant Therapeutics
- Your email: who you already know at Vibrant Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Vibrant Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Vibrant Therapeutics develops multispecific antibody-based prodrugs with conditional activation and targeted delivery for patients with oncological, autoimmune, and neurological diseases. It runs computational drug discovery platforms (BumbleBee, LogicBee, NeuroBee) that combine proteomics analysis and antibody engineering to design biotherapeutics.
Investors · 2
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
Pfizer Venturesreported
How we know: convention.bio.org · Not right? Tell us
In the news
Frequently asked questions
- What does Vibrant Therapeutics do?
- Vibrant Therapeutics develops multispecific antibody-based prodrugs with conditional activation and targeted delivery for patients with oncological, autoimmune, and neurological diseases. It runs computational drug discovery platforms (BumbleBee, LogicBee, NeuroBee) that combine proteomics analysis and antibody engineering to design biotherapeutics.
- Who are Vibrant Therapeutics's investors?
- Vibrant Therapeutics's investors include Pfizer Venture Investments, Pfizer Ventures.